Miranda Thomas

6.4k citations

70 papers · 5.2k indexed · 2 hit papers · h-index 33

Impact in

Oncology top 1%
- Cancer-related Molecular Pathways
Epidemiology top 1%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies

Papers in ⓘ

Cell Biology 17
- Hippo pathway signaling and YAP/TAZ 15
Epidemiology 34
- Cervical Cancer and HPV Research 30

Co-authors: Lawrence Banks (62 shared papers)David Pim (13 shared papers)Greg Matlashewski (6 shared papers)Ann Kalita (4 shared papers)Paola Massimi (19 shared papers)Alan Storey (5 shared papers)Catherine Harwood (4 shared papers)Sylvie Labrecque (1 shared paper)
Journals: Oncogene (11 papers)Journal of Virology (10 papers)Journal of General Virology (3 papers)Virology (3 papers)Nature (2 papers)
Partner nations: Italy United States United Kingdom

In The Last Decade

Miranda Thomas

66 papers receiving 5.1k citations

Hit Papers

align trajectories log scale

Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically 1999 · 603 citations

Peers

Countries citing papers authored by Miranda Thomas

Since Specialization

Citations

This map shows the geographic impact of Miranda Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda Thomas more than expected).

Fields of papers citing papers by Miranda Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda Thomas. The network helps show where Miranda Thomas may publish in the future.

Co-authors

The 25 scholars most cited alongside Miranda Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Miranda Thomas Line = papers co-authored together Miranda Thomas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer Nature ·Alan Storey, Miranda Thomas, Ann Kalita, Catherine Harwood, Daniela Gardiol, Fiamma Mantovani, Judith Breuer, I.M. Leigh, Greg Matlashewski, Lawrence Banks Hit paper breakdown →	1998	797
2	Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically Molecular and Cellular Biology ·Miranda Thomas, Ann Kalita, Sylvie Labrecque, David Pim, Lawrence Banks, Greg Matlashewski Hit paper breakdown →	1999	603
3	The role of the E6-p53 interaction in the molecular pathogenesis of HPV Oncogene ·Miranda Thomas, David Pim, Lawrence Banks	1999	354
4	Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins Genes & Development ·Sarah Jackson, Catherine Harwood, Miranda Thomas, Lawrence Banks, Alan Storey	2000	249
5	Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins Oncogene ·Britt A. Glaunsinger, Siu Sylvia Lee, Miranda Thomas, Lawrence Banks, Ronald T. Javier	2000	242
6	Inhibition of Bak-induced apoptosis by HPV-18 E6 Oncogene ·Miranda Thomas, Lawrence Banks	1998	228
7	Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation Oncogene ·Miranda Thomas, Richard Laura, Karin Hepner, Ernesto Guccione, Charles L. Sawyers, Laurence A. Lasky, Lawrence Banks	2002	166
8	Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types. Journal of General Virology ·Miranda Thomas, Lawrence Banks	1999	154
9	Human papillomaviruses, cervical cancer and cell polarity Oncogene ·Miranda Thomas, Nisha Narayan, D. Pim, Vjekoslav Tomaić, Paola Massimi, Kazunori Nagasaka, Christian Kranjec, Noor Gammoh, Lawrence Banks	2008	141
10	The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins Oncogene ·Miranda Thomas, Paola Massimi, Christel Navarro, Jean‐Paul Borg, Lawrence Banks	2005	111
11	The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy Viruses ·Ketaki Ganti, Justyna Broniarczyk, Wiem Manoubi, Paola Massimi, Suruchi Mittal, David Pim, Anita Szalmás, Jayashree Thatte, Miranda Thomas, Vjekoslav Tomaić, Lawrence Banks	2015	105
12	Structures of a Human Papillomavirus (HPV) E6 Polypeptide Bound to MAGUK Proteins: Mechanisms of Targeting Tumor Suppressors by a High-Risk HPV Oncoprotein Journal of Virology ·Yi Zhang, J. Dasgupta, Z. Runlin, Lawrence Banks, Miranda Thomas, Xiaojiang S. Chen	2007	105
13	HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation Oncogene ·Paola Massimi, Noor Gammoh, Miranda Thomas, Lawrence Banks	2004	102
14	Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes Journal of Cell Science ·Richard A. Watson, Miranda Thomas, Lawrence Banks, Sally Roberts	2003	98
15	Human papillomavirus E6 and E7: What remains? SHILAP Revista de lepidopterología ·Arushi Vats, Óscar Trejo-Cerro, Miranda Thomas, Lawrence Banks	2021	95
16	Viruses and the 26S proteasome: hacking into destruction Trends in Biochemical Sciences ·Lawrence Banks, David Pim, Miranda Thomas	2003	95
17	HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation Oncogene ·Miranda Thomas, Britt A. Glaunsinger, David Pim, Ron Javier, Lawrence Banks	2001	92
18	HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase Oncogene ·David Pim, Miranda Thomas, Ron Javier, Daniela Gardiol, Lawrence Banks	2000	85
19	PDZ domains: the building blocks regulating tumorigenesis Biochemical Journal ·Sudhir Krishna, Christian Kranjec, Miranda Thomas, Lawrence Banks	2011	79
20	Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. PubMed ·Pim D, Alan Storey, Miranda Thomas, Paola Massimi, Lawrence Banks	1994	79

About Miranda Thomas

Miranda Thomas is a scholar working on Cell Biology, Epidemiology, Oncology, Virology and Immunology, having authored 70 papers that have together received 5.2k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (30 papers), Cancer-related Molecular Pathways (22 papers), Hippo pathway signaling and YAP/TAZ (15 papers), Cancer-related gene regulation (11 papers), Ubiquitin and proteasome pathways (10 papers), Virus-based gene therapy research (9 papers), Wnt/β-catenin signaling in development and cancer (7 papers) and T-cell and Retrovirus Studies (6 papers). The work is most often cited by research in Oncology (2.4k citations), Epidemiology (2.4k citations), Cancer Research (712 citations), Otorhinolaryngology (181 citations) and Cell Biology (620 citations). Miranda Thomas has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Lawrence Banks, David Pim, Greg Matlashewski, Ann Kalita, Paola Massimi, Alan Storey, Catherine Harwood, Sylvie Labrecque, Daniela Gardiol and Fiamma Mantovani. Their work appears in journals such as Oncogene, Journal of Virology, Journal of General Virology, Virology and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact